| Riverdell Care Center | |
| 1121 11th Street, Boonville, Missouri 65233 | |
| (660) 882-7600 | |
| Name | Riverdell Care Center |
|---|---|
| Location | 1121 11th Street, Boonville, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 74.5% |
| Medicare ID (CCN) | 265361 |
| Legal Business Name | Boonville No2 Inc |
| Ownership Type | For Profit - Individual |
| NPI Number | 1740212760 |
| Organization Name | BOONVILLE NO2 INC |
| Doing Business As | RIVERDELL CARE CENTER |
| Address | 1121 11th St, Boonville, MO 65233 |
| Phone Number | 660-882-7600 |
News Archive
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures - distinguishing cancer from benign conditions, and identifying patients with high-risk disease.
A brand new technology that promises a range of applications from treating cancer to powering safer nuclear reactors has reached another world first in its development. This milestone was confirmed yesterday, 31 March 2011, at the Science and Technology Facilities Council's Daresbury Laboratory in Cheshire.
An analysis of intensive care unit use in the USA reveals that many patients admitted to this specialist department are at low risk for mortality, while more than half of patients with a high mortality risk are admitted to other departments.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
Kennedy Krieger Institute announced today the opening of the new Center for Genetic Muscle Disorders that will improve and expand services to individuals with muscle disorders such as muscular dystrophy and congenital myopathy in the Baltimore/Washington region and across the nation. The Center provides expert clinical care to children and adults with these disorders, and offers leading research programs both in the clinical and laboratory setting.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures - distinguishing cancer from benign conditions, and identifying patients with high-risk disease.
A brand new technology that promises a range of applications from treating cancer to powering safer nuclear reactors has reached another world first in its development. This milestone was confirmed yesterday, 31 March 2011, at the Science and Technology Facilities Council's Daresbury Laboratory in Cheshire.
An analysis of intensive care unit use in the USA reveals that many patients admitted to this specialist department are at low risk for mortality, while more than half of patients with a high mortality risk are admitted to other departments.
Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.
Kennedy Krieger Institute announced today the opening of the new Center for Genetic Muscle Disorders that will improve and expand services to individuals with muscle disorders such as muscular dystrophy and congenital myopathy in the Baltimore/Washington region and across the nation. The Center provides expert clinical care to children and adults with these disorders, and offers leading research programs both in the clinical and laboratory setting.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 28.89 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.74 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 14.93 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.65 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.28 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.87 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.59 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.77 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 19.51 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.97 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.37 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.45 | 95.98 |